Mills? syndrome: Reporting the disease course with a monthly intravenous immunoglobulin program

被引:1
|
作者
Algahtani, Hussein [1 ,2 ,3 ]
Shirah, Bader [2 ,3 ]
Algahtani, Sarah [4 ]
Attar, Ahmed [1 ]
Abuzinadah, Ahmad R. [5 ,6 ]
机构
[1] King Abdul Aziz Med City, Jeddah, Saudi Arabia
[2] King Saud bin Abdulaziz Univ Hlth Sci, Jeddah, Saudi Arabia
[3] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia
[4] Ibn Sina Natl Coll, Jeddah, Saudi Arabia
[5] King Abdulaziz Univ, Coll Med, Internal Med Dept, Neurol Div, Jeddah, Saudi Arabia
[6] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Jeddah, Saudi Arabia
关键词
Mills? syndrome; Intravenous immunoglobulin; Motor neuron disease; Saudi Arabia; LATERAL-SCLEROSIS; HEMIPLEGIA;
D O I
10.1016/j.jneuroim.2021.577562
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mills? syndrome is an extremely rare, slowly progressive, unilateral ascending or descending clinical syndrome of upper motor neuron?predominant hemiparesis. In this article, we describe a case of a middle-aged woman (initial presentation and three years follow-up) who presented with progressive ascending hemiparesis with clinically isolated upper motor neuron signs and normal sensory examination. The patient received monthly intravenous immunoglobulin (IVIG) for three years with no progression of her weakness. To our best knowledge, the response of Mills? syndrome to such an IVIG program has not been reported in the literature so far. We aim to document the clinical response to IVIG in such rare syndrome.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Monthly intravenous immunoglobulin for refractory intestinal IgA vasculitis
    Shimizu, Masaki
    Irabu, Hitoshi
    Shimbo, Asami
    Kaneko, Shuya
    Mori, Masaaki
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [2] Is a second course of intravenous immunoglobulin treatment in Guillain-Barre syndrome justifiable?
    Yang, Jingyan
    Jia, Rufu
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 77 : 251 - 252
  • [3] Intravenous immunoglobulin and autoimmune disease
    El-Shanawany, Tariq
    Jolles, Stephen
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 507 - 515
  • [4] Intravenous immunoglobulin therapy of antiphospholipid syndrome
    Sherer, Y
    Levy, Y
    Shoenfeld, Y
    RHEUMATOLOGY, 2000, 39 (04) : 421 - 426
  • [5] Intravenous immunoglobulin therapy in antiphospholipid syndrome
    Emiliana Konova
    Clinical Reviews in Allergy & Immunology, 2005, 29 : 229 - 236
  • [6] Intravenous immunoglobulin therapy in antiphospholipid syndrome
    Konova, E
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 29 (03) : 229 - 236
  • [7] Intravenous Immunoglobulin Treatment for Macrophage Activation Syndrome Complicating Chronic Granulomatous Disease
    Alvarez-Cardona, Aristoteles
    Luisa Rodriguez-Lozano, Ana
    Blancas-Galicia, Lizbeth
    Eduardo Rivas-Larrauri, Francisco
    Yamazaki-Nakashimada, Marco A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (02) : 207 - 211
  • [8] Intravenous Immunoglobulin Treatment for Macrophage Activation Syndrome Complicating Chronic Granulomatous Disease
    Aristóteles Álvarez-Cardona
    Ana Luisa Rodríguez-Lozano
    Lizbeth Blancas-Galicia
    Francisco Eduardo Rivas-Larrauri
    Marco A. Yamazaki-Nakashimada
    Journal of Clinical Immunology, 2012, 32 : 207 - 211
  • [9] Treatment of Kimura Disease With Intravenous Immunoglobulin
    Hernandez-Bautista, Victor
    Antonio Yamazaki-Nakashimada, Marco
    Vazquez-Garcia, Ruben
    Stamatelos-Albarran, Daniela
    Carrasco-Daza, Daniel
    Luisa Rodriguez-Lozano, Ana
    PEDIATRICS, 2011, 128 (06) : E1633 - E1635
  • [10] Intravenous Immunoglobulin Resistant Kawasaki Disease
    Navaeifar, Mohammad Reza
    Rezai, Mohammad Sadegh
    JOURNAL OF PEDIATRICS REVIEW, 2013, 1 (01) : 51 - 60